Cooper PE Ratio 2006-2020 | COO

Current and historical p/e ratio for Cooper (COO) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of March 31, 2020 is 22.67.
Cooper PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-03-31 275.67 30.33
2020-01-31 346.89 $9.09 38.16
2019-10-31 291.00 $9.34 31.16
2019-07-31 337.40 $8.94 37.74
2019-04-30 289.92 $8.57 33.83
2019-01-31 278.76 $7.35 37.93
2018-10-31 258.28 $2.78 92.91
2018-07-31 260.47 $2.54 102.55
2018-04-30 228.66 $2.60 87.95
2018-01-31 244.61 $3.49 70.09
2017-10-31 240.17 $7.52 31.94
2017-07-31 243.78 $6.97 34.98
2017-04-30 200.24 $6.67 30.02
2017-01-31 184.52 $6.07 30.40
2016-10-31 175.93 $5.59 31.47
2016-07-31 182.35 $5.11 35.69
2016-04-30 152.96 $4.23 36.16
2016-01-31 131.04 $3.94 33.26
2015-10-31 152.20 $4.14 36.76
2015-07-31 176.81 $4.02 43.98
2015-04-30 177.85 $4.91 36.22
2015-01-31 157.46 $5.30 29.71
2014-10-31 163.67 $5.52 29.65
2014-07-31 160.65 $6.04 26.60
2014-04-30 131.70 $6.03 21.84
2014-01-31 124.08 $5.93 20.92
2013-10-31 128.97 $5.96 21.64
2013-07-31 127.12 $6.27 20.27
2013-04-30 110.17 $5.84 18.87
2013-01-31 101.14 $5.44 18.59
2012-10-31 95.75 $5.06 18.92
2012-07-31 75.08 $4.75 15.81
2012-04-30 87.93 $4.17 21.09
2012-01-31 71.94 $3.78 19.03
2011-10-31 69.08 $3.62 19.08
2011-07-31 76.25 $3.50 21.78
2011-04-30 74.63 $3.58 20.85
2011-01-31 57.14 $2.95 19.37
2010-10-31 49.14 $2.43 20.22
2010-07-31 38.70 $2.06 18.79
2010-04-30 38.70 $1.68 23.04
2010-01-31 35.15 $2.12 16.58
2009-10-31 27.85 $2.21 12.60
2009-07-31 27.29 $2.20 12.40
2009-04-30 28.56 $2.11 13.53
2009-01-31 18.84 $1.82 10.35
2008-10-31 16.34 $1.44 11.35
2008-07-31 33.42 $0.28 119.36
2008-04-30 34.68 $0.06 578.04
2008-01-31 39.02 $-0.20 0.00
2007-10-31 41.59 $-0.23 0.00
2007-07-31 49.64 $0.58 85.58
2007-04-30 50.57 $0.85 59.49
2007-01-31 47.20 $1.15 41.05
2006-10-31 56.99 $1.42 40.14
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.702B $2.653B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.307B 19.76
McKesson (MCK) United States $23.932B 9.39
AmerisourceBergen (ABC) United States $18.221B 12.22
Cardinal Health (CAH) United States $13.988B 8.73
Align Technology (ALGN) United States $13.699B 35.07
Laboratory Of America Holdings (LH) United States $12.298B 11.18
Straumann Holding AG (SAUHF) Switzerland $11.784B 0.00
West Pharmaceutical Services (WST) United States $11.243B 46.99
DENTSPLY SIRONA (XRAY) United States $8.598B 15.85
Henry Schein (HSIC) United States $7.244B 14.39
SmileDirectClub (SDC) United States $1.795B 0.00
Merit Medical Systems (MMSI) United States $1.726B 21.26
CONMED (CNMD) United States $1.632B 21.61
Patterson (PDCO) United States $1.465B 10.19
STAAR Surgical (STAA) United States $1.451B 67.21
Atrion (ATRI) United States $1.206B 32.94
Antares Pharma (ATRS) United States $0.391B 0.00
Invacare (IVC) United States $0.252B 0.00
Lifevantage (LFVN) United States $0.147B 12.41
Pro-Dex (PDEX) United States $0.063B 16.88
Milestone Scientific (MLSS) United States $0.061B 0.00
Retractable Technologies (RVP) United States $0.051B 19.50
Endologix (ELGX) United States $0.013B 0.00
Biolase (BIOL) United States $0.012B 0.00